What is NDC 75907-405?

75907-405 is the product NDC for Bosutinib, Bosutinib 400 mg/1 tablet, film coated, listed with the FDA by Dr. Reddy's Laboratories Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Dr. Reddy's Laboratories Inc., NDC labeler code 75907. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bosutinib?

4 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bosutinib NDC 75907-405 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)75907-405Labeler and product segments. Claims need a package NDC.

Product NDC at billing width75907-0405Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
75907-405-30	7590704053075907040530	30 TABLET, FILM COATED in 1 BOTTLE (75907-405-30)Marketed from Jun 12, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bosutinib
Generic name (nonproprietary): bosutinib
Active ingredients: Bosutinib — 400 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Dr. Reddy's Laboratories Inc.NDC labeler code 75907
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209624
Marketing start: Jun 12, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Bcr-Abl Tyrosine Kinase Inhibitors (Mechanism)
Identifiers: Product ID 75907-405_cb7a8d1d-07c0-462d-960f-214d44705e76SPL ID cb7a8d1d-07c0-462d-960f-214d44705e76SPL set ID cb7a8d1d-07c0-462d-960f-214d44705e76RxCUI 1987732UNII 5018V4AEZ0UPC 0375907405303
Pharmacologic class: Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N475907040530 followed by a unit qualifier and the quantity

Package 75907-0405-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 25, 2026.

Indications (excerpt from the label)

Bosutinib tablets are indicated for the treatment of: Adult patients with chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML), newly-diagnosed or resistant or intolerant to prior therapy [see Clinical Studies ( 14.1 , 14.2 )] . Adult patients with accelerated phase (AP), or blast phase (BP) Ph+ CML with resistance or intolerance to prior therapy [see Clinical Studies (14.2 )]. Pediatric use information is approved for PF PRISM CV’s BOSULIF ® (bosutinib) tablets. However, due to PF PRISM CV’s marketing exclusivity rights, this drug product is not labeled with that information. Bosutinib tablets are a kinase inhibitor indicated for the treatment of adult …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 75907-405

What is NDC 75907-405?: 75907-405 is the product NDC for Bosutinib, Bosutinib 400 mg/1 tablet, film coated, listed with the FDA by Dr. Reddy's Laboratories Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bosutinib.
What is the active ingredient?: Bosutinib.
Who is the labeler?: Dr. Reddy's Laboratories Inc., NDC labeler code 75907. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bosutinib?: 4 other product NDCs are listed under this name. See all Bosutinib NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Bosutinib NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Bosutinib	Bosutinib 100 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-311	46708-0311-35
Bosutinib	Bosutinib 500 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-312	46708-0312-30
Bosutinib	Bosutinib 100 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-311	62332-0311-35
Bosutinib	Bosutinib 500 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-312	62332-0312-30